A Director at Codexis is Exercising Options


Today it was reported that a Director at Codexis (NASDAQ: CDXS), Dennis Wolf, exercised options to sell 36,666 CDXS shares at $10.69 a share, for a total transaction value of $548.9K.

Following Dennis Wolf’s last CDXS Sell transaction on August 30, 2016, the stock climbed by 11.2%. In addition to Dennis Wolf, one other CDXS executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Codexis’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $13.54 million and GAAP net loss of $3.74 million. In comparison, last year the company earned revenue of $10.35 million and had a GAAP net loss of $6.28 million. Currently, Codexis has an average volume of 526.2K. The Company has a Price to Book ratio of 15.4830.

The insider sentiment on Codexis has been negative according to 35 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Codexis, Inc. engages in the discovery, development, and sale of proteins. It offers enzyme optimization services and developing biocatalyst products. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts